Advertisement

 

 

Joint estimation of CD4 progression and survival in untreated individuals with HIV-1 infection: A pooled analysis of data from 25 countries.

Joint estimation of CD4 progression and survival in untreated individuals with HIV-1 infection: A pooled analysis of data from 25 countries.
Author Information (click to view)

Mangal TD,


Mangal TD, (click to view)

Mangal TD,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

AIDS (London, England) 2017 03 15() doi 10.1097/QAD.0000000000001437

Abstract
OBJECTIVE
We compiled the largest dataset of seroconverter cohorts to date from 25 countries across Africa, North America, Europe, and SE/E. Asia to simultaneously estimate transition rates between CD4 stages and death, in ART-naive HIV-1 infected individuals.

DESIGN
A hidden Markov model incorporating a misclassification matrix was used to represent natural short-term fluctuations and measurement errors in CD4 counts. Covariates were included to estimate the transition rates and survival probabilities for each subgroup.

RESULTS
The median follow-up time for 16,373 eligible individuals was 4·1 (IQR 1·7-7·1) years and the mean age at seroconversion was 31·1 (standard deviation 8·8) years. 14,525 individuals had recorded CD4 counts pre-ART, 1,885 died, and 6,947 initiated ART. Median (IQR) survival for males aged 20 years at seroconversion was 13·0 (12 4 – 13·4), 11·6 (10 9 – 12·3) and 8·3 (7 9 – 8·9) years in, Europe/North America, Africa and South-East/East Asia, respectively. Mortality rates increase with age (hazard ratio [HR] 2·22, 95% CI 1·84 – 2·67 for >45 years compared with <25 years) and vary by region (HR 2·68, 1·75 - 4·12 for Africa and 1·88, 1·50 - 2·35 for Asia compared with Europe/North America). CD4 decline was significantly faster in Asian cohorts compared with Europe/North America (HR 1·45, 1·36 - 1·54). CONCLUSIONS
Mortality and CD4 progression rates exhibited regional and age-specific differences, with decreased survival in African and SE/E. Asian cohorts compared with Europe/North America and in older age-groups. This extensive dataset reveals heterogeneities between regions and ages, which should be incorporated into future HIV models.

Submit a Comment

Your email address will not be published. Required fields are marked *

3 + eighteen =

[ HIDE/SHOW ]